Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EPO for Preterm Brain Injury
NCT02036073Phase 4Completed
- Sponsor
- Zhengzhou Children's Hospital
- Start
- Jan 2009
- Primary completion
- Jun 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of erythropoietin in traumatic brain injury (TBI), neurodevelopmental disorder (NDD), sponsored by Zhengzhou Children's Hospital. Started Jan 2009; status: completed.
02
Drugs
erythropoietin
03
Conditions
traumatic brain injury (TBI)neurodevelopmental disorder (NDD)
Beyond the preview
Go deeper on NCT02036073.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02036073.